» Recent Yaz DVT Lawsuits Have Doctors Seeking Safer Treatment Using  External Medical Devices

Recent Yaz DVT Lawsuits Have Doctors Seeking Safer Treatment Using External Medical Devices

Tampa, FL (Law Firm Newswire) March 14, 2013 – Oral contraceptives manufactured by Bayer are being blamed for complications including deep vein thrombosis.

The drugs, called Yaz and Yasmin, became popular in the United States in 2006. Between 2004 and 2008, the FDA received reports of more than 50 deaths blamed on the drugs. Studies have shown a correlation between the drugs and higher rates of deep vein thrombosis (DVT), pulmonary embolism (PE) and blood clots.

Greg Grambor, President of Vascular PRN, a distributor of DVT prevention devices, commented, “Deep vein thrombosis is a serious condition that is often treated with prescription blood thinners, which can be expensive and have serious potential side effects themselves. Fortunately, the condition is very treatable using external medical devices.”

A lawsuit was recently filed against Bayer in California on behalf of 10 plaintiffs. It references a 2002 study published in the British Medical Journal connecting Yaz to DVT and PE.

“Vascular PRN offers a range of devices that prevent DVT by massaging the limbs using sequential compression,” Grambor continued. “This enhances blood flow and prevents clots.”

DVT and PE involve the formation of clots in the cardiovascular system. If these clots break free and enter vital organs, they can be life-threatening. A clot in the brain can cause a stroke, or a clot in the heart can cause a heart attack.

“A woman who wishes to continue taking Yaz but is concerned about side effects could, with a doctor's prescription, use a portable compression device like the PolyGel Ca5 unit as a precautionary measure. This device is user-friendly and lightweight and can be used while driving a car, watching TV, or sleeping,” Grambor added.

DVT and PE are seen most often in elderly, bedridden patients who must be moved and turned frequently by caregivers in order to prevent blood clots.

“Our DVT prevention devices are widely used in nursing homes and hospitals on bedridden patients. They are invaluable to treatment facilities in avoiding medical malpractice lawsuits because they are so effective at preventing dangerous blood clots,” Grambor said.

To learn more about a Sequential Compression Device, SCD boots, or the Skin IQ™ coverlet, visit www.vascularprn.com or call 800-886-4331.

Vascular PRN
601 S. Falkenburg Road, Suite 1-4
Tampa, FL 33619
Phone: 800.886.4331


View Larger Map

  • Providers Leverage the Latest Dementia Research to Create High Quality Care
    From Senior Living Executive magazine:  Senior living providers are discovering that when it comes to serving residents with cognitive impairments, senior housing needs to do the things it already does well, just at a much higher level. The July/August issue of Senior Living Executive magazine talks to senior living leaders about how they are connecting the […]
  • OSHA Adopts Expanded Enforcement against Hospitals, Nursing Homes, and Residential Care Facilities
    The Occupational Safety and Health Administration has announced a new and stricter enforcement policy for the healthcare industry, promising to crack down on the most common hazards in hospitals, nursing homes, and residential care facilities. The new federal enforcement policy, which OSHA expects states to adopt, as well, requires that OSHA inspections in these healthcare facilities focus […]
  • Hospitals find ways to reduce COPD readmissions
    From www.healthcaredive.com  Researchers at Atlanta-based Barnes Healthcare Services recently conducted a study to see if a patient management program that included non-invasive ventilators and in-home care would reduce readmission rates for patients with COPD. The study, which was co-authored and funded by Royal Phillips and published in the Journal of Sleep Medicine, examined 397 patients […]


See other news sources publishing this article. BETA | Tags: , , , , , , , ,



Get headlines from Law Firm Newswire sent right to your inbox.

* indicates required